We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current AADI market cap is 74.68M. The company's latest EPS is USD -2.6682 and P/E is -1.29.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.96M | 6.33M | 5.35M | 6.18M | 7.21M |
| Operating Income | -17.85M | -17.71M | -19.51M | -15.58M | -13.41M |
| Net Income | -16.3M | -16.27M | -18.29M | -14.58M | -12.55M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 15M | 1.12M | 15.22M | 24.35M |
| Operating Income | -24.44M | -6.36M | -111.22M | -62.68M | -71.93M |
| Net Income | -23.27M | -4.32M | -220.18M | -60.51M | -65.77M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 139.66M | 132.42M | 111.07M | 101.62M | 85.7M |
| Total Liabilities | 21.46M | 27.23M | 20.61M | 22.83M | 16.83M |
| Total Equity | 118.2M | 105.2M | 90.46M | 78.79M | 68.87M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 39.94M | 44.93M | 157.91M | 184.24M | 132.42M |
| Total Liabilities | 3.4M | 1.87M | 21.5M | 25.86M | 27.23M |
| Total Equity | 36.54M | 43.06M | 136.41M | 158.38M | 105.2M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -50.02M | -59.66M | -19.65M | -28.81M | -44.5M |
| Investing | 79.56M | 83.21M | 10.56M | 6.98M | 12.07M |
| Financing | 246k | 326k | -10k | 77k | 77k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -23.85M | -5.39M | -22.42M | -49.64M | -59.66M |
| Investing | -237k | -19k | 25.15M | -132.89M | 83.21M |
| Financing | N/A | 9.48M | 141.8M | 72.61M | 326k |
| Market Cap | 74.68M |
| Price to Earnings Ratio | -1.29 |
| Price to Sales Ratio | 3.48 |
| Price to Cash Ratio | 1.35 |
| Price to Book Ratio | 0.81 |
| Dividend Yield | - |
| Shares Outstanding | 24.65M |
| Average Volume (1 week) | 134.99k |
| Average Volume (1 Month) | 118.51k |
| 52 Week Change | 40.28% |
| 52 Week High | 3.46 |
| 52 Week Low | 1.21 |
| Spread (Intraday) | 0.45 (13.08%) |
| Company Name | Aadi Bioscience Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.aadibio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
